Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA.

@article{Laird2015DurabilityOT,
  title={Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA.},
  author={John R. Laird and Peter A. Schneider and Gunnar Tepe and Marianne Brodmann and Thomas Zeller and Christopher D Metzger and Prakash Krishnan and Dierk Scheinert and Antonio Micari and David Jacques Cohen and Hong Wang and Melissa S. Hasenbank and Michael R. Jaff},
  journal={Journal of the American College of Cardiology},
  year={2015},
  volume={66 21},
  pages={2329-2338}
}
BACKGROUND Evidence from large, randomized, controlled peripheral artery disease trials reporting long-term outcomes using drug-coated balloons (DCBs) is limited. Previously, the DCB showed favorable 1-year outcomes compared with conventional percutaneous transluminal angioplasty (PTA), yet durability of the treatment effect with DCBs remains unknown. OBJECTIVES This study sought to investigate the longer-term outcomes of a paclitaxel-eluting DCB compared to PTA for femoropopliteal lesions… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 25 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 64 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 35 references

SMART Nitinol self-expanding stent in the treatment of obstructive superficial femoral artery disease: three-year clinical outcomes from the STROLL Trial

  • M. Jaff
  • Paper presented at: International Symposium on…
  • 2014

Similar Papers

Loading similar papers…